Fig. 11From: Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulationImprovement in “pattern VEP” according to study timepoints (T0, T2) in the eye treated with only WJ-MSC (Table 3, patient 6: left eye). a Before application, P100 latency 152 ms, P100 amplitude 1.6 mV b at 4th month, P100 latency 152 ms, P100 amplitude 6.5 mVBack to article page